These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 12034807)

  • 1. Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
    Pulczynski EJ; Simonsen MR; Kuittinen O; Fagerli UM; Erlanson M; Fluge Ø; Leppä S; Østenstad B; Fosså A; Eriksson M; El-Galaly T; Kuitunen H; Papworth K; Ljungqvist M; Pedersen MB; Pollari M
    Haematologica; 2024 Jul; 109(7):2359-2363. PubMed ID: 38546689
    [No Abstract]   [Full Text] [Related]  

  • 2. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
    Godfrey JK; Gao L; Shouse G; Song JY; Pak S; Lee B; Chen BT; Kallam A; Baird JH; Marcucci G; Ghoda L; Vauleon S; Danilov AV; Herrera AF; Kwak LW; Budde LE
    Blood; 2024 Jul; 144(4):457-461. PubMed ID: 38484137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a future for maintenance temozolomide chemotherapy in PCNSL?
    Bromberg JEC; Doorduijn JK
    Neuro Oncol; 2023 Apr; 25(4):699-700. PubMed ID: 36655502
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
    Grommes C
    J Clin Oncol; 2023 Mar; 41(9):1649-1651. PubMed ID: 36669147
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective.
    Thomas A; Houillier C; Antoni D; Hoang-Xuan K; Soussain C; Jacob J; Feuvret L
    Rep Pract Oncol Radiother; 2023; 28(2):271-285. PubMed ID: 37456704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Use of High Dose Methotrexate in Treatment of Primary CNS Lymphoma Patients Without Access to Serum Methotrexate Levels Monitoring: Challenges and Outcome.
    Singh C; Jain A; Takkar A; Agarwal A; Rohilla M; Lad D; Khadwal A; Basher R; Radotra BD; Bal A; Das A; Gupta V; Lal V; Varma S; Malhotra P; Prakash G
    Indian J Hematol Blood Transfus; 2022 Jan; 38(1):68-77. PubMed ID: 35125713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China.
    Chen C; Sun P; Cui J; Yan S; Chen H; Xia Y; Bi X; Liu P; Wang Y; Yang H; Nie M; Zhang XW; Jiang W; Li ZM
    Cancer Med; 2019 Apr; 8(4):1359-1367. PubMed ID: 30821418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma.
    Li X; Xu X; Chen K; Wu H; Wang Y; Yang S; Wang K
    Pathol Oncol Res; 2020 Apr; 26(2):707-714. PubMed ID: 30712191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
    Wang H; Wang M; Wei J; Wang L; Mao L; Jin J
    J Int Med Res; 2018 Feb; 46(2):883-894. PubMed ID: 28984175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
    Glass J; Won M; Schultz CJ; Brat D; Bartlett NL; Suh JH; Werner-Wasik M; Fisher BJ; Liepman MK; Augspurger M; Bokstein F; Bovi JA; Solhjem MC; Mehta MP
    J Clin Oncol; 2016 May; 34(14):1620-5. PubMed ID: 27022122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL).
    Salamoon M; Hussein T; Kenj M; Bachour M
    Med Oncol; 2013 Dec; 30(4):690. PubMed ID: 23959450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
    Jiang X; Reardon DA; Desjardins A; Vredenburgh JJ; Quinn JA; Austin AD; Herndon JE; McLendon RE; Friedman HS
    J Neurooncol; 2013 Aug; 114(1):135-40. PubMed ID: 23686298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment.
    Adachi J; Mishima K; Wakiya K; Suzuki T; Fukuoka K; Yanagisawa T; Matsutani M; Sasaki A; Nishikawa R
    J Neurooncol; 2012 Mar; 107(1):147-53. PubMed ID: 21968944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status.
    Makino K; Nakamura H; Hide T; Kuratsu J
    J Neurooncol; 2012 Jan; 106(1):155-60. PubMed ID: 21720808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status.
    Kurzwelly D; Glas M; Roth P; Weimann E; Lohner H; Waha A; Schabet M; Reifenberger G; Weller M; Herrlinger U
    J Neurooncol; 2010 May; 97(3):389-92. PubMed ID: 19841864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.
    Kadoch C; Dinca EB; Voicu R; Chen L; Nguyen D; Parikh S; Karrim J; Shuman MA; Lowell CA; Treseler PA; James CD; Rubenstein JL
    Clin Cancer Res; 2009 Mar; 15(6):1989-97. PubMed ID: 19276270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
    Omuro AM; Taillandier L; Chinot O; Carnin C; Barrie M; Hoang-Xuan K
    J Neurooncol; 2007 Nov; 85(2):207-11. PubMed ID: 17896079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma.
    Pels H; Schlegel U
    Curr Treat Options Neurol; 2006 Jul; 8(4):346-57. PubMed ID: 16942677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line therapy with temozolomide induces regression of primary CNS lymphoma.
    Herrlinger U; Küker W; Platten M; Dichgans J; Weller M
    Neurology; 2002 May; 58(10):1573-4. PubMed ID: 12034807
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.